Huaren Pharmaceutical Co., Ltd. (300110.SZ) SHZ

3.25

-0.06(-1.81%)

Updated at January 15 12:13PM

Currency In CNY

Valuation

Market Cap4.16B
Enterprise Value4.89B
P/E Ratio-2.73
PEG Ratio-0.03
Price/Sales Ratio3.07
Price/Book Ratio2.83
Enterprise/Revenue4.05
Enterprise/EBITDA-3.72

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-1.13
Operating Margin-1.12

Management Effectiveness

Return On Assets-0.41
Return On Equity-1.06

Income Statement

Revenue1.35B
Revenue/Share1.06
Gross Profit476.33M
EBITDA-1.18B
Net Income-1.37B
Diluted EPS-1.16

Balance Sheet

Total Cash222.89M
Total Cash/Share0.19
Total Debt1.44B
Total Debt/Equity1.07
Current Ratio0.74
Book Value Per Share1.21

Price History

52-Week Change-5.25
52-Week High3.75
52-Week Low2.71
Moving Average 50 Days3.36
Moving Average 200 Days3.31

Statistics

Average Volume23.53M
Shares Outstanding1.18B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.02
Last Split Factor287:250
Last Split DateFebruary 09, 2018